Loading your page…

Pharmaceutical group

CNX

16 medicines5 countries

A group of 3 companies with 16 medicines in 5 countries.

Its medicines

Group structure

3 companies in 2 countries

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

16 medicines

Medicine	Substance	Country	Status	Authorised
CARDIOXANEPolvere per soluzione per infusione endovenosa	Dexrazoxane	Italy	Authorised
Cardioxane 500 mg poeder voor oplossing voor infusiePoeder voor oplossing voor infusie	Dexrazoxane	Netherlands	Authorised	2006
CARDIOXANE 500 mg POLVO PARA SOLUCION PARA PERFUSION500 mg · Polvo para solución para perfusión	Dexrazoxane	Spain	Marketed	2006
Foragen 100 mg harde capsules met gereguleerde afgifteCapsule met gereguleerde afgifte, hard	Nitrofurantoin	Netherlands	Authorised	2024
Pregabaline CNX 165 mg tabletten met verlengde afgifteTablet met verlengde afgifte	Pregabalin	Netherlands	Authorised	2024
Pregabaline CNX 330 mg tabletten met verlengde afgifteTablet met verlengde afgifte	Pregabalin	Netherlands	Authorised	2024
Pregabaline CNX 82,5 mg tabletten met verlengde afgifteTablet met verlengde afgifte	Pregabalin	Netherlands	Authorised	2024
SATIVEXSpray per mucosa orale, soluzione	Tetraidrocanabinol, Cannabidiol	Italy	Authorised
SATIVEX2.5 mg / act + 2.7 mg / act · Spray (Metered-Dose)	Cannabidiol, Delta-9-tetrahydrocannabinol	Canada	Marketed	2005
SATIVEX 2,7 MG/2,5 MG SOLUCION PARA PULVERIZACION BUCAL38 - 44 mg + 35 - 42 mg · Solución para pulverización bucal	Dronabinol, Cannabidiol	Spain	Marketed	2010
Sativex, spray voor oromucosaal gebruikSpray voor oromucosaal gebruik	Cannabis sativa blad en bloem extract, chemotype cannabidiol, Cannabis sativa blad en bloem extract, chemotype tetrahydrocannabiol	Netherlands	Authorised	2012
Savene	Dexrazoxane	EU (EMA)	Authorised	2006
SAVENESoluzione per infusione	Dexrazoxane	Italy	Authorised
SAVENE 20 mg/ml POLVO PARA CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION20 mg · Polvo y disolvente para concentrado para solución para perfusión	Dexrazoxane	Spain	Marketed	2007
Savene 500 mg, poeder en oplosmiddel voor oplossing voor infusieOplosmiddel voor parenteraal gebruik, Poeder voor oplossing voor injectie	Dexrazoxane	Netherlands	Authorised	2006
SUMATRIPTAN CNX THERAPEUTICSFilm orosolubile	Sumatriptan	Italy	Authorised

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Companies
Netherlands	7	7	Companies All medicines
Italy	4	4	Companies All medicines
Spain	3	3	Companies All medicines
Canada	1	1	Companies All medicines
European Union (EMA)	1	1	Companies All medicines

Also in the registers of France, United Kingdom

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 14 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Companies Registration Office / An Oifig um Chlárú Cuideachtaí

Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/

Licence: Creative Commons Attribution

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

CNX

Group structure

France1

Ireland1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇫🇷France1

🇮🇪Ireland1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

France1

Ireland1